Areti Malapetsa

736 total citations
16 papers, 624 citations indexed

About

Areti Malapetsa is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Areti Malapetsa has authored 16 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Genetics. Recurrent topics in Areti Malapetsa's work include DNA Repair Mechanisms (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Areti Malapetsa is often cited by papers focused on DNA Repair Mechanisms (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Areti Malapetsa collaborates with scholars based in Canada, United States and China. Areti Malapetsa's co-authors include Lawrence Panasci, Irina Orlova, Karin Hübner, Verena Nordhoff, Raquel Aloyz, Andrea S. Bauer, Hans R. Schöler, Georgios Christodoulopoulos, Gérard Mohr and Sasha Belenkov and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Analytical Biochemistry and Biochemical Pharmacology.

In The Last Decade

Areti Malapetsa

16 papers receiving 611 citations

Peers

Countries citing papers authored by Areti Malapetsa

Since Specialization

Citations

This map shows the geographic impact of Areti Malapetsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Areti Malapetsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Areti Malapetsa more than expected).

Fields of papers citing papers by Areti Malapetsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Areti Malapetsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Areti Malapetsa. The network helps show where Areti Malapetsa may publish in the future.

Co-authorship network of co-authors of Areti Malapetsa

This figure shows the co-authorship network connecting the top 25 collaborators of Areti Malapetsa. A scholar is included among the top collaborators of Areti Malapetsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Areti Malapetsa. Areti Malapetsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program 2002 ·Anti-Cancer Drugs ·Zhiyuan Xu, Zhong-Ping Chen, Areti Malapetsa, Moulay A. Alaoui‐Jamali, Josée Bergeron, Anne Monks, Timothy G. Myers, Gérard Mohr, Edward A. Sausville, Dominic A. Scudiero, Raquel Aloyz, Lawrence Panasci	43
2	Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines. 2002 ·PubMed ·(unknown), Areti Malapetsa, Anne Monks, Timothy G. Myers, Gérard Mohr, Edward A. Sausville, Dominic A. Scudiero, Lawrence Panasci	9
3	Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. 2002 ·PubMed ·Raquel Aloyz, Zhiyuan Xu, (unknown), Josée Bergeron, Fei‐Yu Han, (unknown), Areti Malapetsa, Moulay A. Alaoui‐Jamali, Alessandra M.V. Duncan, Lawrence Panasci	72
4	Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences 2001 ·Mammalian Genome ·Verena Nordhoff, Karin Hübner, Andrea S. Bauer, Irina Orlova, Areti Malapetsa, Hans R. Schöler	142
5	Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. 2001 ·PubMed ·Lawrence Panasci, (unknown), Georgios Christodoulopoulos, Sasha Belenkov, Areti Malapetsa, Raquel Aloyz	79
6	Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients. 1999 ·PubMed ·(unknown), Daniel B. Yarosh, (unknown), Donatella Tampieri, Gérard Mohr, Areti Malapetsa, Adrian Langleben, Lawrence Panasci	33
7	Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia. 1999 ·PubMed ·Georgios Christodoulopoulos, Areti Malapetsa, Hyman M. Schipper, Efim I. Golub, Charles M. Radding, Lawrence Panasci	47
8	Evidence for Nucleotide Excision Repair as a Modifying Factor ofO6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines 1997 ·Molecular Pharmacology ·Zhong-Ping Chen, Areti Malapetsa, (unknown), Daniela Di Marcantonio, (unknown), Gérard Mohr, Joanna S. Remack, Thomas P. Brent, Lawrence Panasci	36
9	Quantitation of ERCC-2 Gene Expression in Human Tumor Cell Lines by Reverse Transcription–Polymerase Chain Reaction in Comparison to Northern Blot Analysis 1997 ·Analytical Biochemistry ·Zhong-Ping Chen, Areti Malapetsa, Gérard Mohr, Susan Brien, Lawrence Panasci	14
10	Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase 1996 ·Mutation Research/DNA Repair ·Areti Malapetsa, (unknown), Guy G. Poirier, Serge Desnoyers, Nathan A. Berger, Lawrence Panasci	10
11	Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity 1996 ·Biochemical Pharmacology ·(unknown), Daniela Di Marcantonio, (unknown), Areti Malapetsa, Lawrence Panasci	13
12	Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reaction. 1996 ·PubMed ·(unknown), Areti Malapetsa, Daniela Di Marcantonio, Gérard Mohr, Susan Brien, Lawrence Panasci	9
13	Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics. 1994 ·PubMed ·(unknown), Areti Malapetsa, Lawrence Panasci	10
14	Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system. 1993 ·Molecular Pharmacology ·(unknown), Areti Malapetsa, Lawrence Panasci	10
15	Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. 1993 ·PubMed ·Jonathan L. Bramson, Jérémie Prévost, Areti Malapetsa, (unknown), Guy G. Poirier, Serge Desnoyers, MA Alaoui-Jamali, Lawrence Panasci	23
16	Increased DNA Synthesis and Repair-Enzyme Expression in Lymphocytes From Patients With Chronic Lymphocytic Leukemia Resistant to Nitrogen Mustards 1991 ·JNCI Journal of the National Cancer Institute ·Romas Geleziunas, (unknown), Areti Malapetsa, (unknown), (unknown), Mark A. Wainberg, John Hiscott, Jonathan L. Bramson, Lawrence Panasci	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact